ETS Specialty Services
Current Gene and Cell Therapy List
Provided by Emerging Therapy Solutions (ETS)
Updated: October 9, 2020
Emerging Therapy Solutions provides access to our “ETS Specialty Services”, which are certain procedures and therapies, plus associated services and supplies, that are used to treat certain complex conditions, and which are found in this therapy list below. NOTE: This list is subject to change with the availability of new therapies and medical innovations.
Service Type (Listed by therapy name)
- Chimeric Antigen Receptor (CAR) T-cell Therapies
- Kymriah® (tisagenlecleucel)
- Yescarta® (axicabtagene ciloleucel)
- Tescartus™ (brexucabtagene autoleucel)
- Gene Therapies
- Zolgensma® (onasemnogene abeparvovec-xioi)
- Luxturna® (voretigene neparvovec)
To learn more about our services, please call us at 877.455.4822 or email us at firstname.lastname@example.org.
*This list only contains cell and gene therapies which may be eligible for coverage. To be covered, any therapy must meet all the other terms and conditions applicable to coverage. This list may be modified at any time by adding or deleting cell or gene therapies. Any such modifications will be made by updating this website page. The version of this list available on any given date is applicable to therapies which may be provided on that date.
© 2020 Emerging Therapy Solutions, Inc. All Rights Reserved. ETS and LifeTrac are trademarks of Emerging Therapy Solutions, Inc. All other trademarks referenced herein are the property of their respective owners.